Abstract
We evaluate Moderna prediction models with Simple Moving Average (SMA) and Wilcoxon Rank-Sum Test1,2,3,4 and conclude that the MRNA stock is predictable in the short/long term. According to price forecasts for (n+4 weeks) period: The dominant strategy among neural network is to HoldBuy MRNA stock.
Keywords: MRNA, Moderna, stock forecast, machine learning based prediction, risk rating, buy-sell behaviour, stock analysis, target price analysis, options and futures.
Key Points
- Stock Forecast Based On a Predictive Algorithm
- What is the best way to predict stock prices?
- Understanding Buy, Sell, and Hold Ratings

MRNA Target Price Prediction Modeling Methodology
We consider Moderna Stock Decision Process with Wilcoxon Rank-Sum Test where A is the set of discrete actions of MRNA stock holders, F is the set of discrete states, P : S × F × S → R is the transition probability distribution, R : S × F → R is the reaction function, and γ ∈ [0, 1] is a move factor for expectation.1,2,3,4
F(Wilcoxon Rank-Sum Test)5,6,7= X R(Simple Moving Average (SMA)) X S(n):→ (n+4 weeks)
n:Time series to forecast
p:Price signals of MRNA stock
j:Nash equilibria
k:Dominated move
a:Best response for target price
For further technical information as per how our model work we invite you to visit the article below:
How do AC Investment Research machine learning (predictive) algorithms actually work?
MRNA Stock Forecast (Buy or Sell) for (n+4 weeks)
Sample Set: Neural NetworkStock/Index: MRNA Moderna
Time series to forecast n: 31 Aug 2022 for (n+4 weeks)
According to price forecasts for (n+4 weeks) period: The dominant strategy among neural network is to HoldBuy MRNA stock.
X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)
Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)
Z axis (Yellow to Green): *Technical Analysis%
Conclusions
Moderna assigned short-term B1 & long-term B1 forecasted stock rating. We evaluate the prediction models Simple Moving Average (SMA) with Wilcoxon Rank-Sum Test1,2,3,4 and conclude that the MRNA stock is predictable in the short/long term. According to price forecasts for (n+4 weeks) period: The dominant strategy among neural network is to HoldBuy MRNA stock.
Financial State Forecast for MRNA Stock Options & Futures
Rating | Short-Term | Long-Term Senior |
---|---|---|
Outlook* | B1 | B1 |
Operational Risk | 85 | 76 |
Market Risk | 85 | 36 |
Technical Analysis | 36 | 67 |
Fundamental Analysis | 46 | 50 |
Risk Unsystematic | 45 | 71 |
Prediction Confidence Score
References
- R. Sutton, D. McAllester, S. Singh, and Y. Mansour. Policy gradient methods for reinforcement learning with function approximation. In Proceedings of Advances in Neural Information Processing Systems 12, pages 1057–1063, 2000
- K. Boda, J. Filar, Y. Lin, and L. Spanjers. Stochastic target hitting time and the problem of early retirement. Automatic Control, IEEE Transactions on, 49(3):409–419, 2004
- Athey S, Imbens G. 2016. Recursive partitioning for heterogeneous causal effects. PNAS 113:7353–60
- G. Konidaris, S. Osentoski, and P. Thomas. Value function approximation in reinforcement learning using the Fourier basis. In AAAI, 2011
- Firth JR. 1957. A synopsis of linguistic theory 1930–1955. In Studies in Linguistic Analysis (Special Volume of the Philological Society), ed. JR Firth, pp. 1–32. Oxford, UK: Blackwell
- Arora S, Li Y, Liang Y, Ma T. 2016. RAND-WALK: a latent variable model approach to word embeddings. Trans. Assoc. Comput. Linguist. 4:385–99
- Bottou L. 1998. Online learning and stochastic approximations. In On-Line Learning in Neural Networks, ed. D Saad, pp. 9–42. New York: ACM
Frequently Asked Questions
Q: What is the prediction methodology for MRNA stock?A: MRNA stock prediction methodology: We evaluate the prediction models Simple Moving Average (SMA) and Wilcoxon Rank-Sum Test
Q: Is MRNA stock a buy or sell?
A: The dominant strategy among neural network is to HoldBuy MRNA Stock.
Q: Is Moderna stock a good investment?
A: The consensus rating for Moderna is HoldBuy and assigned short-term B1 & long-term B1 forecasted stock rating.
Q: What is the consensus rating of MRNA stock?
A: The consensus rating for MRNA is HoldBuy.
Q: What is the prediction period for MRNA stock?
A: The prediction period for MRNA is (n+4 weeks)